KPA to brace for tougher measures over reimbursable OTCs

Published: 2003-05-19 06:59:00

Updated: 2003-05-19 06:59:00

The Korea Pharmaceutical Association said recently that it has opted for the license cancellation of some OTC products whose supplier prices at pharmacy are found to be higher than insurance-covered prices by resorting to a revision of the current enforcement regulations of the Korea Pharmaceutic...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK